300255 常山药业
已收盘 04-10 15:00:00
资讯
新帖
简况
4月1日常山药业涨5.72%,医药LOF基金重仓该股
证券之星 · 04-01
4月1日常山药业涨5.72%,医药LOF基金重仓该股
常山药业(300255)发布为全资子公司提供担保的进展公告,3月27日股价上涨5.01%
证券之星 · 03-27
常山药业(300255)发布为全资子公司提供担保的进展公告,3月27日股价上涨5.01%
常山药业:通过药物研究院构建药物研发与信息共享中心
证券之星 · 03-23
常山药业:通过药物研究院构建药物研发与信息共享中心
常山药业:公司在持续关注GLP-1药物研究最新前沿信息
证券之星 · 03-23
常山药业:公司在持续关注GLP-1药物研究最新前沿信息
常山药业:股东协议转让股份事项目前仍在进行中
证券之星 · 03-23
常山药业:股东协议转让股份事项目前仍在进行中
常山药业:艾本那肽用于减重适应症的临床试验尚未完成准备工作
证券之星 · 03-11
常山药业:艾本那肽用于减重适应症的临床试验尚未完成准备工作
常山药业:截至2026年3月10日,公司的股东户数为47739户
证券之星 · 03-11
常山药业:截至2026年3月10日,公司的股东户数为47739户
常山药业(300255.SZ):依诺肝素钠注射液获得塔吉克斯坦药品注册证书
智通财经 · 03-06
常山药业(300255.SZ):依诺肝素钠注射液获得塔吉克斯坦药品注册证书
3月4日常山药业跌5.88%,医药LOF基金重仓该股
中金财经 · 03-04
3月4日常山药业跌5.88%,医药LOF基金重仓该股
常山药业(300255)2月27日股东户数4.72万户,较上期增加4.15%
证券之星 · 03-02
常山药业(300255)2月27日股东户数4.72万户,较上期增加4.15%
常山药业:艾本那肽上市审评处于正常流程中
证券之星 · 03-02
常山药业:艾本那肽上市审评处于正常流程中
常山药业:CSCJC3456片临床试验仍在进行中
证券之星 · 02-26
常山药业:CSCJC3456片临床试验仍在进行中
常山药业:艾本那肽后续审评进展请以后续公示信息为准
证券之星 · 02-26
常山药业:艾本那肽后续审评进展请以后续公示信息为准
2月25日常山药业涨8.87%,医药LOF基金重仓该股
证券之星 · 02-25
2月25日常山药业涨8.87%,医药LOF基金重仓该股
常山药业最新公告:公司部分药品拟中选国家组织集采药品协议期满品种接续采购
证券之星 · 02-14
常山药业最新公告:公司部分药品拟中选国家组织集采药品协议期满品种接续采购
2月12日常山药业跌6.11%,医药LOF基金重仓该股
证券之星 · 02-12
2月12日常山药业跌6.11%,医药LOF基金重仓该股
常山药业:截至2026年2月10日,公司的股东户数为44260户
证券之星 · 02-11
常山药业:截至2026年2月10日,公司的股东户数为44260户
常山药业(300255)披露为全资子公司提供担保的进展公告,2月6日股价上涨1.19%
证券之星 · 02-06
常山药业(300255)披露为全资子公司提供担保的进展公告,2月6日股价上涨1.19%
2月5日常山药业跌5.20%,医药LOF基金重仓该股
证券之星 · 02-05
2月5日常山药业跌5.20%,医药LOF基金重仓该股
常山药业:艾本那肽上市审评处于正常流程中
证券之星 · 02-05
常山药业:艾本那肽上市审评处于正常流程中
加载更多
公司概况
公司名称:
河北常山生化药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-08-19
主营业务:
河北常山生化药业股份有限公司的主营业务是肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售。公司的主要产品是肝素钠粗品、肝素钠原料药、肝素钠注射液、低分子量肝素钙原料药和低分子量肝素钙注射液、依诺肝素钠原料药和依诺肝素钠注射液、那屈肝素钙原料药和那屈肝素钙注射液、达肝素钠原料药和达肝素钠注射液。公司近几年分别被认定为国家企业技术中心、中国创业创新典型示范企业、河北省A级研发中心、国家级高新技术企业、国家地方工程实验室、河北省多糖类药物工程技术研究中心、河北省出口名牌等,建立了国家级博士后科研工作站,有效推动公司高级人才引进和创新驱动发展。
发行价格:
28.00
{"stockData":{"symbol":"300255","market":"SZ","secType":"STK","nameCN":"常山药业","latestPrice":41.06,"timestamp":1775804601000,"preClose":41.42,"halted":0,"volume":19542136,"delay":0,"changeRate":-0.0087,"floatShares":918000000,"shares":919000000,"eps":-0.3282,"marketStatus":"已收盘","change":-0.36,"latestTime":"04-10 15:00:00","open":41.44,"high":42.01,"low":40.8,"amount":809000000,"amplitude":0.0292,"askPrice":41.06,"askSize":384,"bidPrice":41.05,"bidSize":35,"shortable":0,"etf":0,"ttmEps":-0.3282,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776043800000},"marketStatusCode":5,"adr":0,"adjPreClose":41.42,"symbolType":"stock","openAndCloseTimeList":[[1775784600000,1775791800000],[1775797200000,1775804400000]],"highLimit":45.56,"lowLimit":37.28,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":919060878,"isCdr":false,"pbRate":25.09,"roa":"--","roe":"--","epsLYR":-0.27,"committee":-0.166338,"marketValue":37737000000,"turnoverRate":0.0213,"status":1,"floatMarketCap":37681000000},"requestUrl":"/m/hq/s/300255","defaultTab":"news","newsList":[{"id":"2624953335","title":"4月1日常山药业涨5.72%,医药LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624953335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624953335?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:16","pubTimestamp":1775031400,"startTime":"0","endTime":"0","summary":"证券之星消息,4月1日常山药业涨5.72%,收盘报39.52元,换手率3.53%,成交量32.43万手,成交额12.71亿元。重仓常山药业的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为国泰基金的医药LOF。医药LOF目前规模为6.54亿元,最新净值0.5478,较上一交易日下跌0.27%,近一年上涨1.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0172","159938","09939","BK0239","BK0070","BK1161","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622820324","title":"常山药业(300255)发布为全资子公司提供担保的进展公告,3月27日股价上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622820324","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622820324?lang=zh_cn&edition=full","pubTime":"2026-03-27 22:06","pubTimestamp":1774620383,"startTime":"0","endTime":"0","summary":"近日,常山药业披露《关于为全资子公司提供担保的进展公告》。公告显示,公司于2026年3月26日与光大银行石家庄分行签订《最高额保证合同》,为全资子公司凯库得提供1,000万元的最高额连带责任保证担保;2026年3月27日,公司与农业银行正定县支行签订《保证合同》,为凯库得1,668.01万元的固定资产借款本金及利息提供连带责任保证。被担保人凯库得为公司全资子公司,非失信被执行人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700049218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0070","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621756877","title":"常山药业:通过药物研究院构建药物研发与信息共享中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2621756877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621756877?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:09","pubTimestamp":1774253351,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)03月23日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好:1、公司有无市值管理理念或措施?2、公司科研团队建设情况?常山药业回复:你好,公司通过药物研究院构建药物研发与信息共享中心,通过新药最新前沿信息的分析、重点研发品种的选择、各类研发资源的整合以及研发人才的引进与培养等途径,发挥公司的创新主体作用。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300023982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","300255","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621077565","title":"常山药业:公司在持续关注GLP-1药物研究最新前沿信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2621077565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621077565?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:09","pubTimestamp":1774253351,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业03月23日在投资者关系平台上答复投资者关心的问题。论坛重点讨论了GLP-1 长效周制剂,与公司核心产品阿贝那肽赛道高度契合,会议传递的心肾代谢获益、减重应用、基层推广等趋势,公司如何把握市场方向?常山药业回复:你好,公司在持续关注GLP-1药物研究最新前沿信息,实现充分利用既有技术成果。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300023986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0172","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621775631","title":"常山药业:股东协议转让股份事项目前仍在进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2621775631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621775631?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:09","pubTimestamp":1774253349,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)03月23日在投资者关系平台上答复投资者关心的问题。投资者提问:公司领导你们好:股份转让是由公司发公告告知中小股东的,目前将近4个月还没结果,希望公司了解一下:目前股份转让是否正常?到了那个环节?谢谢!常山药业回复:你好。公司经向股东了解,股东协议转让股份事项目前仍在进行中。该事项由股东主导,公司不方便代替股东介绍交易细节。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300023978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0172","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618499917","title":"常山药业:艾本那肽用于减重适应症的临床试验尚未完成准备工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2618499917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618499917?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:54","pubTimestamp":1773219256,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:减肥适应症临床几时开始,是否需要等待减重获批常山药业回复:你好。艾本那肽用于减重适应症的临床试验尚未完成准备工作,开展减重临床试验无需等待降糖适应症审批结果。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100027430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0172","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618917298","title":"常山药业:截至2026年3月10日,公司的股东户数为47739户","url":"https://stock-news.laohu8.com/highlight/detail?id=2618917298","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618917298?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:54","pubTimestamp":1773219250,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止3月10日公司的股东人数是多少?谢谢!常山药业回复:你好。截至2026年3月10日,公司的股东户数为47739户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100027427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0172","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617727500","title":"常山药业(300255.SZ):依诺肝素钠注射液获得塔吉克斯坦药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2617727500","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617727500?lang=zh_cn&edition=full","pubTime":"2026-03-06 15:45","pubTimestamp":1772783150,"startTime":"0","endTime":"0","summary":"智通财经APP讯,常山药业(300255.SZ)发布公告,公司于近日收到通知,公司药品依诺肝素钠注射液获得塔吉克斯坦药品监督管理部门签发的药品注册证书。依诺肝素钠注射液用于预防静脉血栓栓塞性疾病(预防静脉内血栓形成),特别是与骨科或普外手术有关的血栓形成;治疗已形成的深静脉栓塞,伴或不伴有肺栓塞,临床症状不严重,不包括需要外科手术或溶栓剂治疗的肺栓塞;与阿司匹林合用,治疗不稳定性心绞痛及非Q波心肌梗死;用于血液透析体外循环中,防止血栓形成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0239","300255","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616538954","title":"3月4日常山药业跌5.88%,医药LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538954","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616538954?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:46","pubTimestamp":1772613985,"startTime":"0","endTime":"0","summary":"证券之星消息,3月4日常山药业跌5.88%创60日新低,收盘报41.9元,换手率2.73%,成交量25.03万手,成交额10.64亿元。重仓常山药业的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为国泰基金的医药LOF。医药LOF目前规模为6.54亿元,最新净值0.5427,较上一交易日下跌2.09%,近一年上涨1.42%。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/04/20260304142482.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/04/20260304142482.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260304/32044382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159938","BK1161","09939","BK0239","BK1515","BK0070","BK0172","BK1574","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616387130","title":"常山药业(300255)2月27日股东户数4.72万户,较上期增加4.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616387130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616387130?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:32","pubTimestamp":1772443956,"startTime":"0","endTime":"0","summary":"证券之星消息,近日常山药业披露,截至2026年2月27日公司股东户数为4.72万户,较2月13日增加1880.0户,增幅为4.15%。在化学制药行业个股中,常山药业股东户数高于行业平均水平,截至2月27日,化学制药行业平均股东户数为3.42万户。从股价来看,2026年2月13日至2026年2月27日,常山药业区间涨幅为8.06%,在此期间股东户数增加1880.0户,增幅为4.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200025689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","BK0070","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616381853","title":"常山药业:艾本那肽上市审评处于正常流程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2616381853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616381853?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:15","pubTimestamp":1772439323,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业03月02日在投资者关系平台上答复投资者关心的问题。贵公司发补资料提交已超过4个月了,目前仍看不到相关公示信息。请问这4个月多时间公司的上市审评是在正常审评中还是被束之高阁了?这个公司应该知晓吧,广大投资者也应有权知悉,请贵公司切实回应投资者关切。艾本那肽上市审评处于正常流程中,未出现异常,审评进展请以后续公示信息为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200021623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","300255","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009403","title":"常山药业:CSCJC3456片临床试验仍在进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009403?lang=zh_cn&edition=full","pubTime":"2026-02-26 15:06","pubTimestamp":1772089579,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)02月26日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,新年好。CSCJC3456片临床试验于2025年2月13日首例入组,至今已有1年了。为了不辜负广大投资者对3456片的期盼,请您介绍一下到目前为止,3456片的临床进展情况。常山药业回复:你好。CSCJC3456片临床试验仍在进行中,如有重大进展公司将根据有关规则予以公告,目前暂无重大事项需要披露。感谢关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600016790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0172","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614942530","title":"常山药业:艾本那肽后续审评进展请以后续公示信息为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614942530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614942530?lang=zh_cn&edition=full","pubTime":"2026-02-26 15:03","pubTimestamp":1772089390,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)02月26日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好!补充资料审评:有些是亮1盏灯,有些亮6盏灯,有可能不亮灯直接行政审批。请问阿贝那肽资料审评是否属于不亮灯这一流程或其他?常山药业回复:你好。创新药审评流程请参阅相关部门发布的法律法规。艾本那肽后续审评进展请以后续公示信息为准。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600016761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300255","BK0239","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614709299","title":"2月25日常山药业涨8.87%,医药LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614709299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614709299?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:28","pubTimestamp":1772008090,"startTime":"0","endTime":"0","summary":"证券之星消息,2月25日常山药业涨8.87%,收盘报46.63元,换手率3.89%,成交量35.69万手,成交额16.67亿元。融资融券方面近5日融资净流出8882.48万,融资余额减少;融券净流入0.0,融券余额增加。重仓常山药业的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为国泰基金的医药LOF。医药LOF目前规模为6.54亿元,最新净值0.567,较上一交易日下跌0.11%,近一年上涨4.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500025456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0172","BK0070","159938","BK0239","BK1161","BK1515","09939","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611336164","title":"常山药业最新公告:公司部分药品拟中选国家组织集采药品协议期满品种接续采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2611336164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611336164?lang=zh_cn&edition=full","pubTime":"2026-02-14 00:20","pubTimestamp":1770999613,"startTime":"0","endTime":"0","summary":"常山药业(300255.SZ)公告称,公司于近日参加了国家组织集采药品协议期满品种接续采购的投标工作,公司部分药品拟中选本次接续采购。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021400000375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610439789","title":"2月12日常山药业跌6.11%,医药LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610439789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610439789?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:40","pubTimestamp":1770885605,"startTime":"0","endTime":"0","summary":"证券之星消息,2月12日常山药业跌6.11%创60日新低,收盘报43.49元,换手率4.08%,成交量37.43万手,成交额16.43亿元。重仓常山药业的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为国泰基金的医药LOF。医药LOF目前规模为6.54亿元,最新净值0.5775,较上一交易日下跌0.05%,近一年上涨9.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200026421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK1161","BK0239","09939","BK0172","BK1515","159938","BK1574","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610061989","title":"常山药业:截至2026年2月10日,公司的股东户数为44260户","url":"https://stock-news.laohu8.com/highlight/detail?id=2610061989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610061989?lang=zh_cn&edition=full","pubTime":"2026-02-11 15:42","pubTimestamp":1770795727,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问:刘董,你好,请问截止2026年2月10日收盘,公司股东户数是多少?谢谢!常山药业回复:你好。截至2026年2月10日,公司的股东户数为44260户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100019955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0172","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609359161","title":"常山药业(300255)披露为全资子公司提供担保的进展公告,2月6日股价上涨1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609359161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609359161?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:06","pubTimestamp":1770386785,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,常山药业报收于46.65元,较前一交易日上涨1.19%,最新总市值为428.74亿元。该股当日开盘46.5元,最高47.5元,最低45.4元,成交额达7.86亿元,换手率为1.83%。近日,常山药业披露《关于为全资子公司提供担保的进展公告》。本次担保在已审批的2,000万元担保额度内,无需另行提交董事会或股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600040659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300255","BK0070","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609322232","title":"2月5日常山药业跌5.20%,医药LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609322232","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609322232?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:40","pubTimestamp":1770280828,"startTime":"0","endTime":"0","summary":"证券之星消息,2月5日常山药业跌5.20%创60日新低,收盘报46.1元,换手率2.51%,成交量23.04万手,成交额10.69亿元。融资融券方面近5日融资净流出1.59亿,融资余额减少;融券净流入0.0,融券余额增加。重仓常山药业的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为国泰基金的医药LOF。医药LOF目前规模为6.54亿元,最新净值0.5716,较上一交易日上涨1.1%,近一年上涨10.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500026256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0172","BK0070","159938","BK0239","BK1161","BK1515","09939","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609614326","title":"常山药业:艾本那肽上市审评处于正常流程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2609614326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609614326?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:03","pubTimestamp":1770274991,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)02月05日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好!从11月3日公司回复阿贝那肽已提交资料算起到今天2月4日已经超过3个月了,67个工作日,至今还没公示消息,是什么原因?同类都没有这么长时间,希望公司了解情况与投资者交流沟通一下!谢谢!常山药业回复:你好。艾本那肽上市审评处于正常流程中,未出现异常。请客观看待创新药上市审评环节多、周期长的特点。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500018901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775835118425,"stockEarnings":[{"period":"1week","weight":-0.0327},{"period":"1month","weight":-0.0288},{"period":"3month","weight":-0.2977},{"period":"6month","weight":-0.1634},{"period":"1year","weight":1.3682},{"period":"ytd","weight":-0.333}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":-0.0381},{"period":"3month","weight":-0.0374},{"period":"6month","weight":0.0177},{"period":"1year","weight":0.2446},{"period":"ytd","weight":-0.0007}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河北常山生化药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"48189人(较上一季度增加0.94%)","perCapita":"19043股","listingDate":"2011-08-19","address":"河北省石家庄市正定县中国(河北)自由贸易试验区正定片区高新技术产业开发区南区梦龙街71号","registeredCapital":"91906万元","survey":" 河北常山生化药业股份有限公司的主营业务是肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售。公司的主要产品是肝素钠粗品、肝素钠原料药、肝素钠注射液、低分子量肝素钙原料药和低分子量肝素钙注射液、依诺肝素钠原料药和依诺肝素钠注射液、那屈肝素钙原料药和那屈肝素钙注射液、达肝素钠原料药和达肝素钠注射液。公司近几年分别被认定为国家企业技术中心、中国创业创新典型示范企业、河北省A级研发中心、国家级高新技术企业、国家地方工程实验室、河北省多糖类药物工程技术研究中心、河北省出口名牌等,建立了国家级博士后科研工作站,有效推动公司高级人才引进和创新驱动发展。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"常山药业,300255,常山药业股票,常山药业股票老虎,常山药业股票老虎国际,常山药业行情,常山药业股票行情,常山药业股价,常山药业股市,常山药业股票价格,常山药业股票交易,常山药业股票购买,常山药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}